Category: Partners

WHITBY, ON / ACCESS Newswire / June 13, 2025 / Consumer Choice Award (CCA) is proud to announce that The Shawn Lepp Group | Keller Williams Energy Lepp Group Real Estate has been named the 2025 Consumer Choice Award Winner in the Residential Real Estate category for the Durham Region. This recognition highlights the group’s proven track record, expert leadership, and commitment to delivering superior service to buyers and sellers alike.

Led by real estate veteran Shawn Lepp, the team has earned a reputation as one of the most effective and trusted in the Durham Region. With more than 100 years of combined experience and over 120 homes sold annually, the group is known for its strategic approach, expert market knowledge, and personalized client care. Each member of the team is a licensed professional, supported by a dedicated staff that ensures every transaction runs smoothly.

“We are incredibly honoured to receive the Consumer Choice Award,” said Shawn Lepp. “This recognition reflects the hard work of our team and the trust our clients place in us every day. Helping people achieve their real estate goals is our passion, and we’re proud to serve the Durham Region with integrity and professionalism.”

At The Shawn Lepp Group, cutting-edge technology and strategic marketing come together to deliver exceptional results. From high-quality photography and video tours to targeted digital advertising and social media exposure, every listing is showcased to attract maximum attention. With data-driven insights and innovative tools, the team ensures your home reaches the right buyers at the right time-helping you sell faster and for top value.

The Shawn Lepp Group offers:

• Residential property buying and selling services

• Strategic marketing and staging consultations

• Neighbourhood insights and local expertise

• Expert negotiation and transaction support

• Personalized guidance throughout the entire real estate journey

The group’s success is built on results and relationships. Whether guiding first-time homebuyers or helping families upgrade or downsize, The Shawn Lepp Group delivers customized solutions that align with each client’s unique needs.

Clients consistently praise the team for its responsiveness, transparency, and depth of market insight-qualities that set it apart in a competitive industry. With a clear commitment to excellence, The Shawn Lepp Group continues to raise the standard for real estate service in the Durham Region.

To learn more about The Shawn Lepp Group or to book a consultation, CLICK HERE or visit www.shawnlepp.com.

About Consumer Choice Award:
Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

Contact Information:
Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire

PIONEERTOWN, CA / ACCESS Newswire / June 13, 2025 / ESCAPE Records releases two transcendent works from its secretive Mojave Desert hub in Pioneertown CA: the Parallel Universe EP, a genre-defying musical odyssey from touring electronic artists and industry veterans, and Gong Song! (Live from Escape, Pioneertown CA), a 45-minute sound healing masterpiece by Alessandra Montana.

Crafted where social media fades to the obscure and creativity thrives, these two new records aim to forge deep audience connections – inspiring a sense of solidarity between the creative and their audience.

The Parallel Universe EP blends electronic, Americana, and Latin vibes, born during a songwriting retreat at ESCAPE’s legendary studio, some 40 miles from the gates of Coachella in the high desert of California, a mile above sea level under a myriad of stars. Listeners are invited to ponder what their life would be like in a parallel universe; evoking poignant emotions in today’s somewhat turbulent world.

Tracks are shared by studio founder and producer ROC Gardner, Latin Grammy-nominated Cimafunk (La Vida), Jamie N Commons (Hold Me While You Wait), DJ Tennis (Life and Death), and Grammy-nominated Jan Blomqvist (Remote Control), joined by producers Joseph Ray (Nero), Daniel Cantisani, Nikko Gibler (Ricoshēi), and Devlin Thorn alongside artists that include Kim Bullard (Elton John) and Craig McClune (David Gray) who lent their expertise to evolving the tracks.

Mixed by Mick Guzauski (Daft Punk, The Weeknd, Michael Jackson) and mastered by Bernie Grundman, tracks include Mezcalita (June 13), Happy Unhappy (June 20), La Sugar (June 27), and Never Know (July 4). BEEPLE’s surreal artwork Naturally Occurring Emoji and an AI-driven video by The Dor Brothers amplify the EP’s cosmic narrative.

“The universal sky we spent each night under sparked something raw,” says ROC. “It was awesome breaking out of our channels – we got to capture all these ideas, unbound by trends or any other concerns – it was great fun!”

Simultaneously, Alessandra Montana’s Gong Song! (Live from Escape) captures a live 45-minute sound journey, recorded meticulously with vintage gear and microphones at ESCAPE. Guided by mixing engineer Rob Columbus and mastered by Grundman, Montana’s gongs and sacred instruments weave a meditative portal for healing.

“Escape’s magic let me share my practice globally. I can’t wait for people to hear this and experience the journey we went on,” says Montana.

ESCAPE, a 140-acre creative haven hosting Rüfüs Du Sol, Arctic Monkeys, Usher, RAYE – and many others – fosters unfiltered artistry. The studio hopes to deliver magic – and its music – unfettered and unfiltered.

Visit www.esca.pe for more.

Assets: Press release, artwork, lyrics, .wav files available upon request.
Interviews: info@esca.pe

Jan Blomqvist appears courtesy of Armada Music B.V.

Tracks:

Mezcalita (1st Single): https://audiosalad.ffm.to/commons-roc-mezcalita

Parallel Universe EP: https://audiosalad.ffm.to/parallel-universe

Gong Song! (Live from Escape): https://audiosalad.ffm.to/gong-song

SOURCE: Escape Records LLC

View the original press release on ACCESS Newswire

BURLINGTON, ON / ACCESS Newswire / June 13, 2025 / Safe ‘N’ Sound Environmental Services Ltd., a Burlington-based environmental remediation firm, has been recognized with the 2025 Consumer Choice Award in the Asbestos Removal category in the Halton Region. This distinction highlights the company’s commitment to providing safe, effective, and fully certified environmental solutions for both residential and commercial clients.

Founded in 2019, Safe ‘N’ Sound Environmental Services has earned a strong reputation for delivering professional asbestos abatement, mold remediation, environmental testing, and hazardous materials management. The company’s team of licensed and trained professionals ensures that each project meets regulatory compliance and exceeds safety expectations.

“Winning the Consumer Choice Award is a testament to our team’s dedication to creating safer environments,” said Michael Rocha, Owner of Safe ‘N’ Sound Environmental Services Ltd. “We take great pride in the trust our clients place in us, and we’re committed to upholding that trust through every project we take on.”

Comprehensive Environmental Services
Safe ‘N’ Sound Environmental Services offers a broad range of remediation and testing services designed to protect the health and safety of property occupants. Their service areas span across Southern Ontario, including homes, businesses, schools, industrial sites, and government buildings.

Core services include:

• Asbestos Testing and Abatement (Types 1, 2, and 3)

• Mold Testing and Remediation

• Air Quality and Bulk Sampling

• Lead and Vermiculite Removal

• Clean Demolition and Site Clearing

• Drug Lab and Biohazard Clean-up

• COVID-19 Sanitizing and Disinfection

• Respiratory Fit Testing

• Certified Training: Asbestos 253W, 253S, WHMIS, Mold Awareness

Each project begins with a thorough consultation and is executed with precision, transparency, and compliance. The team uses advanced equipment, industry-approved methods, and follows all Ministry of Labour regulations to ensure work is completed safely and effectively.

Respected by Industry Leaders and Homeowners Alike
Safe ‘N’ Sound Environmental Services has been a four-time recipient of the Halton Business Excellence Award and is widely known as a trusted name among homeowners, contractors, and developers. The company is also a preferred environmental contractor for Bryan Baeumler, a well-known Canadian builder and television personality-reinforcing its status as a respected and skilled remediation partner.

Client reviews regularly highlight the company’s professionalism, quick turnaround times, and commitment to delivering peace of mind in high-stakes environments.

Advancing Environmental Safety
With this latest recognition, Safe ‘N’ Sound Environmental Services Ltd. remains focused on expanding its reach and reinforcing its role as a leader in environmental safety across Southern Ontario. The company plans to continue developing specialized services and growing its team of certified professionals to meet rising demand for safe demolition, hazard containment, and indoor environmental quality.

“We understand the responsibility that comes with what we do,” added Rocha. “Whether it’s a family home or a large commercial site, our mission stays the same: protect people, follow the science, and deliver solutions that last.”

To learn more about Safe ‘N’ Sound Environmental Services Ltd. and their range of services, CLICK HERE or visit www.safensoundenvironmentalservices.ca.

About Consumer Choice Award:
Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

Contact Information:
Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire

Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older

CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345), the Company’s respiratory syncytial virus (RSV) vaccine, for the prevention of lower respiratory tract disease (LRTD) caused by RSV in individuals 18-59 years of age who are at increased risk for disease. This approval expands the previous indication of mRESVIA, which was approved in May 2024 for adults aged 60 years and older.

“RSV poses a serious health risk to adults with certain chronic conditions, and today’s approval marks an important step forward in our ability to protect additional populations from severe illness from RSV,” said Stéphane Bancel, Chief Executive Officer of Moderna. “We appreciate the FDA’s review and thank all the participants in our clinical trial as well as the Moderna team for their dedication to protecting people against RSV.”

While the risk of RSV is well recognized in infants and older adult populations, adults aged 18-59 years with chronic conditions are also vulnerable.¹ Over one-third of adults aged 18-59 years have at least one underlying condition that puts them at increased risk of severe RSV disease,² with disease burden and hospitalization rates in this population being comparable, or even exceeding, that observed in older adults.³

This approval was supported by results from Moderna’s Phase 3 study (NCT06067230), which evaluated the safety and immunogenicity of mRESVIA in adults aged 18-59 with underlying health conditions. The immune responses against both RSV-A and RSV-B met prespecified non-inferiority immunobridging criteria when compared to those observed in adults aged 60 years and older in the pivotal Phase 3, placebo-controlled safety and efficacy study. Comparable levels of neutralizing antibodies were observed across both the 18-49 and 50-59 age subgroups, supporting the vaccine’s consistent immunogenicity profile in this at-risk, younger adult population. These findings were presented at the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) meeting in April 2025 and have been published in Clinical Infectious Diseases.

The vaccine was generally well-tolerated, and the most commonly reported solicited adverse reactions were injection site pain, fatigue, headache, myalgia and arthralgia.

Moderna intends to have mRESVIA available for both younger adults at increased risk (ages 18-59) and older adults (ages 60+) in the U.S. for the 2025-2026 respiratory virus season.

About mRESVIA® (Respiratory Syncytial Virus Vaccine)

mRESVIA® is an RSV vaccine that consists of an mRNA sequence encoding a stabilized prefusion F glycoprotein. The F glycoprotein is expressed on the surface of the virus and is required for infection by helping the virus to enter host cells. The prefusion conformation of the F protein is a significant target of potent neutralizing antibodies and is highly conserved across both RSV-A and RSV-B subtypes. The vaccine uses the same lipid nanoparticles (LNPs) as the Moderna COVID-19 vaccines.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

mRESVIA® is a registered trademark of Moderna.

INDICATION
mRESVIA is a vaccine to protect you against lower respiratory tract disease caused by Respiratory Syncytial Virus (RSV).

mRESVIA is for people 60 years of age and older and also for people 18 through 59 years of age who are at increased risk for RSV (people with medical conditions such as diabetes or with diseases affecting the lungs and heart). Vaccination with mRESVIA may not protect all people who receive the vaccine.

mRESVIA does not contain RSV. mRESVIA cannot give you lower respiratory tract disease caused by RSV.

IMPORTANT SAFETY INFORMATION

Who should not get mRESVIA?

You should not get mRESVIA if you had a severe allergic reaction to any ingredient in mRESVIA.

What should you tell your healthcare provider?

Tell your healthcare provider about all of your medical conditions, including if you:

• Have any allergies

• Had a severe allergic reaction after receiving a previous dose of any other vaccine

• Have a fever

• Have a bleeding disorder or are on a blood thinner

• Are immunocompromised or are on a medicine that affects your immune system

• Have received any other RSV vaccine

• Have ever fainted in association with an injection

How is mRESVIA given?

mRESVIA is given as an injection into the muscle.

What are the risks of mRESVIA?

There is a very small chance that mRESVIA could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to one hour after getting a dose of mRESVIA. For this reason, your healthcare provider may ask you to stay for a short time at the place where you received your vaccine. Signs of a severe allergic reaction may include:

• Trouble breathing

• Swelling of your face and throat

• A fast heartbeat

• A rash all over your body

• Dizziness and weakness

Side effects that have been reported in clinical trials with mRESVIA include:

• Injection-site reactions: pain, underarm swelling or tenderness in the same arm of the injection, swelling (hardness), and redness

• Fatigue, headache, muscle pain, joint pain, chills, nausea or vomiting, fever and hives

These may not be all of the possible side effects of mRESVIA. Ask your healthcare provider about any side effects that concern you. You may report side effects to the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 or https://vaers.hhs.gov.

Please click for mRESVIA Full Prescribing Information.

Moderna Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: the efficacy, safety and tolerability of mRESVIA; the disease burden associated with RSV, particularly in adults with certain risk factors; and the availability of mRESVIA for the 2025-2026 season. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.

Moderna Contacts

Media:
Chris Ridley
Head of Global Media Relations
+1 617-800-3651
Chris.Ridley@modernatx.com

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
+1 617-209-5834
Lavina.Talukdar@modernatx.com

³ Weycker D, Averin A, Houde L, et al. Rates of Lower Respiratory Tract Illness in US Adults by Age and Comorbidity Profile. Infect Dis Ther 2024; 13(1): 207-20.

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

BROOKLYN, NY / ACCESS Newswire / June 12, 2025 / IEH Corporation (OTC PINK:IEHC) today filed with the Securities and Exchange Commission (SEC) its Annual Report on Form 10-K for the fiscal year ended March 31, 2025.

Highlights include:

• 34% Increase in Revenue over Fiscal Year 2024

• $4.34M Improvement in Operating Income

• 72% increase in cash on hand, compared to prior year

For the Fiscal Year ended March 31, 2025, IEH had revenues of $28,783,861 as compared to $21,524,544 for the Fiscal Year ended March 31, 2024 reflecting a 33.7% increase; operating income of $574,862 for Fiscal Year 2025 as compared to an operating loss of $3,760,887 for Fiscal Year 2024 reflecting a $4,335,749 improvement; net income of $999,038 for Fiscal Year 2025 as compared to a net loss of $2,916,902 for Fiscal Year 2024 reflecting a $3,915,940 improvement; and a basic earnings per share of $.42 as compared to a basic loss per share of $1.23 for Fiscal Year 2024.

Dave Offerman, President and CEO of IEH Corporation commented, “By almost any discernible metric, IEH’s financial health has improved considerably this past year. Our revenue was 3^rd-highest in our history, our cash position has improved dramatically since this time last year, inventory relative to revenue is down, and we were profitable in both operating and net income. Our margins continue to be lower than desired due to the rise in our material costs, but price adjustments implemented over the last several months will bolster our gross margins going forward and be reflected in future financial statements. After declining for several months, our backlog has stabilized, and our sales pipeline remains strong. Changes in the competitive landscape offer opportunities to win market share, and we continue to intensify our marketing efforts to target new industries for our signature Hyperboloid products.

As previously noted, growth and improvements may still be uneven from one quarter to the next while the commercial aircraft industry continues to produce below their target levels, but our long-term forecasts for that sector, along with strong growth projections in our defense-related business and commercial space launch bode well for IEH in the years ahead.

So while it’s possible that revenue in Fiscal Year 2026 will be slightly lower than 2025, the overall strength of our sales pipeline, along with efforts underway to improve our product mix and diversify our markets served, should lead to considerable long-term growth.

On behalf of the management team and staff of IEH, we again wish to express our sincere gratitude for the support of our valued shareholders. We look forward to sharing more positive news in the coming months and quarters.”

About IEH Corporation

For over 80 years and 4 generations of family-run management, IEH Corporation has designed, developed, and manufactured printed circuit board (PCB) connectors, custom interconnects and contacts for high performance applications. With its signature Hyperboloid technology, IEH supplies the most durable, reliable connectors for the most demanding environments. The Company markets primarily to companies in defense, aerospace, medical, space and industrial applications, in the United States, Canada, Europe, Southeast and Central Asia and the Mideast. The Company was founded in 1941 and is headquartered in Brooklyn, New York.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain statements contained in this press release, and in related comments by the Company’s management, include “forward-looking statements.” All statements, other than statements of historical facts, including, without limitation, statements or expectations regarding our financial condition, statements or expectations regarding our revenues, cash and backlog, expectations regarding future cash requirements, revenue and revenue recovery, including for fiscal year 2026 and beyond, projected timelines for making our SEC filings or successfully preventing our registration from suspension or revocation and expectations regarding our efforts and ability to resolve our inventory accounting issues are forward-looking statements. These statements often include words such as “believe,” “expect,” “estimate,” “plan,” “will,” “may,” “would,” “should,” “could,” or similar expressions, although not all forward-looking statements contain such identifying words. These statements are based on certain assumptions that the Company has made on its current expectations and projections about future events. The Company believes these judgments are reasonable, but you should understand that these statements are not guarantees of performance or results, and you should not place undue reliance on any forward-looking statements. The Company’s actual performance or results could differ materially from those expressed in the forward-looking statements due to a variety of important factors, both positive and negative, as they will depend on many factors about which we are unsure, including many factors beyond our control. Among other items, such factors could include: any claims, investigations or proceedings arising as a result of our past due periodic reports, including changes in the proceedings related to the SEC’s Order Instituting Administrative Proceedings and Notice of Hearing pursuant to Section 12(j) of the Securities and Exchange Act of 1934, as amended; our ability to remediate our inventory accounting issue; our ability to reduce costs or increase revenue; changes in the macroeconomic environment or in the finances of our customers; changes in accounting principles, or their application or interpretation, and our ability to make accurate estimates and the assumptions underlying the estimates; our ability to attract and retain key employees and key resources; and other risk factors discussed from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on June 12, 2025, and in subsequent reports filed with or furnished to the SEC. Additional information concerning these and other factors can be found in our filings with the SEC. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. Except as may be required by applicable law, we do not undertake or intend to update or revise our forward-looking statements, and we assume no obligation to update any forward-looking statements contained in this press release as a result of new information or future events or developments. Thus, you should not assume that our silence over time means that actual events are bearing out as expressed or implied in such forward-looking statements. You should carefully review and consider the various disclosures we make in our filings with the SEC that attempt to advise interested parties of the risks, uncertainties and other factors that may affect our business.

Contact:

Dave Offerman
IEH Corporation
dave@iehcorp.com
718-492-4448

SOURCE: IEH Corp.

View the original press release on ACCESS Newswire

The campaign will air nationally on CNBC, FOX Business, Bloomberg, and inside NTTS’s weekly investor-focused television broadcasts-along with distribution across New to The Street’s 2.6M YouTube subscriber channel.

NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / New to The Street, a leading multi-platform financial media brand, proudly announces the launch of a new national commercial campaign for its featured client, Arrive AI (NASDAQ:ARAI). The high-impact TV commercial will be distributed across major financial news networks including CNBC, FOX Business, and Bloomberg, and will be fully integrated into New to The Street’s weekly syndicated TV series reaching more than 220 million U.S. homes.

View commercial now:

The spot will also air across New to The Street’s powerful digital network-including its YouTube channel with over 2.6 million subscribers, one of the largest financial video audiences in the world.

The campaign shines a spotlight on Arrive AI’s patented autonomous delivery platform, emphasizing its smart mailbox technology, U.S. patent portfolio, and its game-changing use cases in healthcare, e-commerce, and temperature-sensitive logistics. It’s a critical moment of visibility for the company as it accelerates commercialization and expands across new sectors.

“Arrive AI is one of the most compelling companies we’ve ever featured,” said Vince Caruso, Creator and Host of New to The Street. “This TV campaign will bring their message to millions of investors, partners, and consumers across all our channels-network TV, outdoor, digital, and our 2.6M-strong YouTube community. We’re proud to help tell their story at scale.”

The commercial will be seen:

• Inside New to The Street’s nationally broadcast segments on FOX Business and Bloomberg

• On CNBC through targeted prime-time media placements

• Digitally across New to The Street’s YouTube Channel (2.6M+ subscribers)

• Programmatically distributed across OTT platforms and digital pre-roll

• Through Accel Media’s iconic outdoor billboard network including Times Square and NYC Financial District

The full-scale media rollout is expected to support upcoming milestones for Arrive AI, including new strategic partnerships, vertical expansion, and additional product announcements.

About Arrive AI (NASDAQ:ARAI):
Arrive AI is building the future of smart logistics with its patented Arrive Points™-AI-powered mailboxes designed to securely manage both autonomous and traditional package deliveries. With eight issued patents and a growing presence in healthcare, e-commerce, and industrial delivery, Arrive AI is revolutionizing last-mile fulfillment infrastructure.

About New to The Street:
New to The Street is a nationally televised business show that features public and private companies, airing as sponsored programming on FOX Business, Bloomberg, and CNBC. It also operates one of the largest financial YouTube channels in the U.S. with over 2.6 million subscribers, supported by robust earned media, digital distribution, and outdoor advertising in Times Square and the NYC Financial District.

Media Contact:
Monica Brennan
PR, New to The Street
Monica@NewToTheStreet.com

Investor Contact:
Dan O’Toole, CEO, Arrive AI
ir@arrive.ai

SOURCE: New To The Street

View the original press release on ACCESS Newswire

NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / On June 11, 2025, Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq:ADUR)(CSE:ACT)(FSE:9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, announced the closing of its underwritten U.S. public offering (the “Offering”) of 947,868 common shares, together with accompanying warrants to purchase 473,934 common shares. The combined public offering price per common share and accompanying half warrant was US$8.44. The Company received gross proceeds of approximately US$8 million, before deducting underwriting discounts and offering expenses. The common shares were sold in combination with an accompanying half warrant (with each whole warrant being exercisable into one common share of the Company). Each whole warrant has an exercise price of US$10.13 per share and are exercisable immediately and will expire three years from the date of issuance.

Acting as the sole book-running manager for the Offering, D. Boral Capital LLC worked closely with Aduro Clean Technologies’s experience CFO, Mr. Mena Beshay on planning and executing this successful transaction.

Aduro intends to use the net proceeds from the offering for ongoing research and development costs, expenditures related to the construction of its “Demonstration-Scale” plant and the remainder (if any) for general corporate purposes and working capital.

In addition, the Company has granted the underwriters a 45-day over-allotment option to purchase up to an additional 142,180 common shares and/or warrants to purchase an additional 71,090 common shares.

The Offering was being made pursuant to an effective shelf registration statement on Form F-10, as amended (File No. 333-287475), previously filed with the U.S. Securities and Exchange Commission (“SEC”) and became effective on May 28, 2025, and the Company’s Canadian short form base shelf prospectus dated May 28, 2025 (the “Base Shelf Prospectus”). Aduro offered and sold the securities in the United States only. No securities were offered or sold to Canadian purchasers.

The Base Shelf Prospectus relating to the Offering and describing the terms thereof has been filed with the applicable securities commissions in Canada and with the SEC in the United States and is available for free by visiting the Company’s profiles on the SEDAR+ website maintained by the Canadian Securities Administrators at www.sedarplus.ca or the SEC’s website at www.sec.gov, as applicable. A final prospectus supplement with the final terms will be filed with the securities regulatory authorities in the Canadian provinces of British Columbia and Ontario and the SEC.

Copies of the final prospectus may be obtained, when available, at the SEC’s website at www.sec.gov or from D. Boral Capital LLC, Attention: 590 Madison Avenue 39th Floor, New York, NY 10022, or by email at dbccapitalmarkets@dboralcapital.com, or by telephone at +1 (212) 970-5150.

Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more complete information about the Company and the Offering. This press release shall not constitute an offer to sell, or the solicitation of an offer to buy any of the Company’s securities, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption from registration, nor shall there be any offer, solicitation or sale of any of the Company’s securities in any state or jurisdiction in which such offers, solicitations or sales would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About Aduro Clean Technologies

Aduro Clean Technologies is a developer of patented water-based technologies to chemically recycle waste plastics; convert heavy crude and bitumen into lighter, more valuable oil; and transform renewable oils into higher-value fuels or renewable chemicals. The Company’s Hydrochemolytic™ Technology relies on water as a critical agent in a chemistry platform that operates at relatively low temperatures and cost, a game-changing approach that converts low-value feedstocks into resources for the 21st century.

About D. Boral Capital

D. Boral Capital LLC is a premier, relationship-driven global investment bank headquartered in New York. The firm is dedicated to delivering exceptional strategic advisory and tailored financial solutions to middle-market and emerging growth companies. With a proven track record, D. Boral Capital provides expert guidance to clients across diverse sectors worldwide, leveraging access to capital from key markets, including the United States, Asia, Europe, the Middle East, and Latin America.

A recognized leader on Wall Street, D. Boral Capital has successfully aggregated approximately $30 billion in capital since its inception in 2020, executing ~350 transactions across a broad range of investment banking products.

Forward-Looking Statement

This press release contains forward-looking statements regarding the Company’s current expectations. These forward-looking statements include, without limitation, references to the Company’s expectations regarding anticipated use of net proceeds from the Offering. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties related to the factors that may result in changes to the Company’s anticipated use of proceeds. These and other risks and uncertainties are described more fully in the section captioned “Risk Factors” in the Company’s annual information form dated May 20, 2025, which is available on SEDAR+ at www.sedarplus.ca, on EDGAR at www.sec.gov. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law, including the securities laws of the United States and Canada.

For more information, please contact:

D. Boral Capital LLC
Email: dbccapitalmarkets@dboralcapital.com
Telephone: +1(212) 970-5150

SOURCE: D. Boral Capital

View the original press release on ACCESS Newswire

NEWPORT BEACH, CA / ACCESS Newswire / June 12, 2025 / Amaze Holdings, Inc. (NYSE American:AMZE) (“Amaze” or the “Company”),a global leader in creator-powered commerce, today announced the results of its annual stockholders’ meeting held today.

1. Election of Directors: Stockholders elected all seven director nominees to serve until the 2026 Annual Meeting of Stockholders.

2. Ratification of Auditors: Stockholders ratified the appointment of Wipfli LLP as the Company’s independent registered public accounting firm for the fiscal year 2025.

3. Series D Preferred Stock Conversion Proposal: Stockholders approved the issuance of common stock upon conversion of the Company’s Series D Convertible Preferred Stock and the exercise of associated warrants, exceeding the “Exchange Share Cap” and “Individual Holder Share Cap” limitations, as provided in the Series D Certificate of Designation. This approval also authorizes a change of control under applicable NYSE American rules.

4. Reverse Stock Split Proposal: Stockholders approved the authorization of a reverse stock split of the Company’s common stock at a ratio between 1-for-10 and 1-for-50..

5. Series A Preferred Stock Conversion Proposal: Stockholders approved the issuance of common stock upon conversion of Series A Convertible Preferred Stock in excess of the applicable share caps under the Certificate of Designation and NYSE American rules.

6. Series B Preferred Stock Conversion Proposal: Stockholders approved the issuance of common stock upon conversion of Series B Convertible Preferred Stock in excess of the applicable share caps.

7. Series C Preferred Stock Conversion Proposal: Stockholders approved the issuance of common stock upon conversion of Series C Convertible Preferred Stock in excess of the applicable share caps.

8. Authorized Common Stock Increase Proposal: Stockholders did not approve an amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of common stock from 100,000,000 to 250,000,000.

9. Equity Plan Amendment Proposal: Stockholders approved an amendment and restatement of the 2021 Equity Incentive Plan to increase the number of shares available for issuance to 20,800,000 shares (prior to the effect of the reverse stock split).

10. ELOC Issuance Proposal: Stockholders approved the issuance of 20% or more of the Company’s issued and outstanding common stock in connection with the securities purchase agreement dated May 6, 2025.

11. Adjournment Proposal: Stockholders approved the proposal to adjourn the annual meeting, if necessary, to solicit additional proxies.

For more information please refer to the Company’s proxy statement filed with the United States Securities and Exchange Commission (SEC) on May 7, 2025.

Reverse Stock Split

Amaze also announced today that it will effect a 1-for-23 reverse stock split at 5:00 p.m. Eastern time today. Beginning with the opening of trading on June 13, 2025, Amaze’s common stock will trade on a split adjusted basis under the new CUSIP number 35804X 200.

The final 1-for-23 ratio was determined by Amaze’s Board of Directors on June 2, 2025, and the reverse stock split was effected by filing a Certificate of Amendment to Amaze’s articles of incorporation on June 12, 2025 with the Secretary of State of the State of Nevada. The reverse stock split is intended to increase the per share market price of Amaze’s common stock to meet the $3.00 per share minimum bid price requirement of the NYSE American.

Additional details regarding the reverse stock split can be found in the Current Report on Form 8-K filed on June 12, 2025 with the SEC as well as the Company’s proxy statement.

For investor information, visit IR@amaze.co

For press inquiries, please contact PR@amaze.co

About Amaze:
Amaze Holdings, Inc. is an end-to-end, creator-powered commerce platform offering tools for seamless product creation, advanced e-commerce solutions, and scalable managed services. By empowering anyone to “sell anything, anywhere,” Amaze enables creators to tell their stories, cultivate deeper audience connections, and generate sustainable income through shoppable, authentic experiences. Discover more at www.amaze.co.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements relate to future events and developments or to our future operating or financial performance, are subject to risks and uncertainties and are based estimates and assumptions. Forward-looking statements may include, but are not limited to, statements about the reverse stock split, our market opportunity and potential growth of that market, strategies, initiatives, growth, revenues, expenditures, our plans and objectives for future operations, and future financial and business performance. These statements can be identified by words such as such as “may,” “might,” “should,” “would,” “could,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential” or “continue,” and are based our current expectations and views concerning future events and developments and their potential effects on us.

These statements are subject to known and unknown risks, uncertainties and assumptions that could cause actual results to differ materially from those projected or otherwise implied by the forward-looking statement. These risks include: our ability to execute our plans and strategies; our limited operating history and history of losses; our financial position and need for additional capital; our ability to attract and retain our creator base and expand the range of products available for sale; we may experience difficulties in managing our growth and expenses; we may not keep pace with technological advances; there may be undetected errors or defects in our software or issues related to data computing, processing or storage; our reliance on third parties to provide key services for our business, including cloud hosting, marketing platforms, payment providers and network providers; failure to maintain or enhance our brand; our ability to protect our intellectual property; significant interruptions, delays or outages in services from our platform; significant data breach or disruption of the information technology systems or networks and cyberattacks; risks associated with international operations; general economic and competitive factors affecting our business generally; changes in laws and regulations, including those related to privacy, online liability, consumer protection, and financial services; our dependence on senior management and other key personnel; and our ability to attract, retain and motivate qualified personnel and senior management.

Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included in our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other future filings and reports that we file with the Securities and Exchange Commission (SEC) from time to time. Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of the press release. Unless required by law, we undertake no obligation to update or revise any forward-looking statements to reflect new information or future events or developments.

SOURCE: Amaze Holdings, Inc.

View the original press release on ACCESS Newswire

Subscription App Available to Millions of U.S. Homes via Xfinity and Xumo

BOCA RATON, FL / ACCESS Newswire / June 12, 2025 / Newsmax Inc. (NYSE:NMAX) (“Newsmax” or the “Company”) today announced that Newsmax+, Newsmax’s streaming service via its subscription app, is now available on Comcast’s entertainment devices across the U.S., including Xfinity X1, Xfinity Flex, Xumo Stream Box and Xumo TV.

The popular Newsmax+ is offered with a free trial and retails for $4.99 per month ($49.99/year). The Plus service includes the Newsmax channel live feed, Newsmax2, the company’s free streaming channel, Newsmax en Espanol and World at War, a military history channel.

Newsmax+ has grown into a news and entertainment service offering family-friendly entertainment including many highly rated programs, documentaries, movies and classic series, including The Beverly Hillbillies, Bonanza, Dragnet and others.

“We’re very excited that Newsmax+ is now available to millions of Xfinity and Xumo customers across the U.S.,” said Andy Biggers, Newsmax’s Senior Vice President of Distribution. “This enables us to reach a wide range of consumers, from streamers to pay-TV subscribers, all of whom can now subscribe and get immediate access to the Newsmax+ app on their TVs.”

About Newsmax

Newsmax Inc. is listed on the NYSE (NMAX) and operates, through Newsmax Broadcasting LLC, one of the nation’s leading news outlets, the Newsmax channel. The fourth highest-rated network is carried on all major cable and satellite systems. Newsmax’s media properties reach more than 40 million Americans regularly through Newsmax TV, the Newsmax App, its popular website Newsmax.com, and publications such as Newsmax Magazine. Through its social media accounts, Newsmax reaches 20 million combined followers. Reuters Institute says Newsmax is one of the top U.S. news brands and Forbes has called Newsmax “a news powerhouse.”

For more information, please visit Investor Relations | Newsmax Inc.

Investor Contacts

Newsmax Investor Relations
ir@newsmax.com

Forward-Looking Statements

This communication contains forward-looking statements. From time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Forward-looking statements can be identified by those that are not historical in nature. The forward-looking statements discussed in this communication and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. Newsmax does not guarantee future results, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. Forward-looking statements should not be relied upon as predictions of future events. We are under no duty to update any of these forward-looking statements after the date of this communication to conform our prior statements to actual results or revised expectations, and we do not intend to do so. Factors that may cause actual results to differ materially from current expectations include various factors, including but not limited to our ability to change the direction of Newsmax, our ability to keep pace with new technology and changing market needs, the competitive environment of our business changes in domestic and global general economic and macro-economic conditions and/or uncertainties and factors set forth in the sections entitled “Risk Factors” in Newsmax’s Annual Report on Form 10-K for the twelve months ended December 31, 2024, Newsmax’s Quarterly Report on Form 10-Q for the three months ended March 31, 2025, and other filings Newsmax makes with the Securities and Exchange Commission. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. Undue reliance should not be placed on forward-looking statements in this communication, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein.

SOURCE: Newsmax Inc.

View the original press release on ACCESS Newswire

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / Pactum, the leading Agentic AI platform for enterprise procurement, today announces the launch of its new AI agent, Price Lists for Direct Materials, designed to transform how organizations manage procurement of under-managed materials at scale by providing the very first end-to-end agentic AI procurement solution.

In today’s volatile market environment, procurement teams face mounting challenges in managing thousands of stock keeping units (SKUs), responding to unpredictable supply chain dynamics, and constrained resources, allowing raw material price increases to go unnoticed. This under managed spend significantly impacts profit margins and adds complexity to supply chain operations.

Pactum’s Price Lists for Direct Materials agent addresses this challenge head-on. Pactum agents can continuously monitor and analyze price changes across a business’ procurement portfolio, identify opportunities, develop tailored negotiation strategies, and autonomously execute deals – ensuring optimal pricing and turning procurement complexity into a streamlined, value generating engine.

“Raw material costs continue to increase over time, especially across large SKU volumes. With our Price Lists agent, every price change is visible, every opportunity is actionable, and every negotiation is handled autonomously. We are not just revolutionizing how companies manage their materials and price lists but constantly generating valuable opportunities. The cash flow and margin that is freed up, gives new ability to make strategic gains,” commented Kaspar Korjus, CEO at Pactum.

Already adopted by five leading manufacturing clients, the Price Lists agent is driving measurable results – reducing costs, improving compliance and enhancing supplier engagement – all without adding to headcount. This launch reinforces Pactum’s commitment to redefining procurement through Agentic AI, empowering organizations to shift from reactive management to proactive, automated negotiation.

This week at DPW New York, Pactum is showcasing its Price Lists for Direct Materials agent with live demonstrations and hands-on sessions. Attendees are invited to connect with the team and explore how Agentic AI is writing the new rule book for procurement.

Visit the website to find out more, or to view the product demonstration: https://youtu.be/3_vbo0BvYww

-ENDS-

About Pactum

Since 2019, Pactum has been leading the agentic AI transformation in procurement, empowering Chief Procurement Officers to add AI agents working alongside humans. Agents work around the clock with autonomy and authority to find negotiation opportunities and close supplier deals at scale. Pactum agents are trusted by over 50 of the world’s largest enterprises, delivering measurable value and enabling agility for procurement operations.

To find out more, please visit the website: https://pactum.com/

Contact

The Jargon Group – pactum@thejargongroup.com
+44 (0)118 973 9370

SOURCE: Pactum

View the original press release on ACCESS Newswire